NICOX OPHTHALMICS INC has a total of 29 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2013. It filed its patents most often in Japan, United States and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are ARNO THERAPEUTICS, GUANGZHOU CELLPROTEK PHARMACEUTICAL CO LTD and GUANGZHOU CELLPROTEK PHARMACEUTICAL LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Japan | 8 | |
#2 | United States | 8 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | China | 2 | |
#5 | Hong Kong | 2 | |
#6 | Australia | 1 | |
#7 | Hungary | 1 | |
#8 | Mexico | 1 | |
#9 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Machines | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Steroids | |
#4 | Organic chemistry methods | |
#5 | Unspecified technologies | |
#6 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Hao Tian | 15 |
#2 | Cavanagh Thomas | 12 |
#3 | Barman Shikha P | 12 |
#4 | Leland Thomas B | 11 |
#5 | Thekkedath Ritesh V | 11 |
#6 | Paul Gomes | 5 |
#7 | Matthew Jonathan Chapin | 5 |
#8 | Mark Barry Abelson | 5 |
#9 | George Minno | 5 |
#10 | Abelson Mark Barry | 5 |
Publication | Filing date | Title |
---|---|---|
CN111821261A | Method for preparing sterile ophthalmic aqueous fluticasone propionate A-type nanocrystal suspension |